Musculoskeletal and joint disease - commissioning policies
Please click on the links below to access the commissioning policies. The associated Equality Impact Assessments, if currently available, are accessible here.

The CCGs’ position on the implementation of policies affecting patient referral can be found here.
Certolizumab for ankylosing spondylitisClick here to download this file
Add this document to cartCertolizumab for psoriatic arthritisClick here to download this file
Add this document to cartCollagenase injection (Xiapex®) for Dupuytren's contractureClick here to download this file
Add this document to cartDupuytren’s contracture treatmentClick here to download this file
Add this document to cartEXOGEN® low intensity pulsed ultrasound (LIPUS) bone healing system for non-union long bone fractures Click here to download this file
Add this document to cartHip and knee replacement surgery in obese patients (those with a body mass index of 30 or greater)Click here to download this file
Add this document to cartRituximab in combination with methotrexate for rheumatoid arthritisClick here to download this file
Add this document to cartRituximab without methotrexate for rheumatoid arthritisClick here to download this file
Add this document to cartTocilizumab subcutaneous injection for rheumatoid arthritisClick here to download this file
Add this document to cart
Please note:  Some commissioning policies approved by the previous commissioning organisations are yet to be reviewed and updated. There is an on-going programme of work in place to review and update these policies. They will then be published under the appropriate category. 

In the meantime they are still applicable to Northern, Eastern and Western Devon CCG. Former NHS Devon policies can be accessed here
Rate this Page.
Great
Okay
Bad